Combither AT 60mg Injection is a prescription antimalarial injection containing 60 mg of artesunate and is used under professional medical supervision for malaria when injectable treatment is clinically appropriate. References identify artesunate as the active ingredient and describe administration by a healthcare professional rather than self-injection. It is important to understand that this medicine treats malaria; it is not a fever medicine and should not be used without a confirmed or strongly suspected clinical indication.

What is Combither AT 60mg Injection?

Combither AT 60mg Injection contains artesunate, a fast-acting antimalarial medicine. The product is listed as a 60 mg injectable preparation and is marketed by Aristo Pharmaceuticals Pvt. Ltd.

Because severe malaria can progress quickly, prompt medical assessment matters. Symptoms can include high fever, chills, sweating, headache, weakness, nausea, vomiting, confusion, breathing problems, anemia, or other signs of organ involvement. A patient with suspected severe malaria needs urgent medical care rather than trying to manage the infection with an over-the-counter product.

Uses and Potential Benefits

The primary purpose of Combither AT 60mg Injection is antimalarial treatment. Combither AT 60mg Injection is selected only when its injectable formulation fits the clinical situation. Artesunate rapidly attacks malaria parasites and helps reduce the parasite burden. Injectable artesunate may be selected when oral treatment is not possible, such as when a patient is vomiting, unconscious, or seriously ill. Product information describes its use in malaria and hospital-based treatment.

The major benefit is rapid parasite clearance, which can help clinicians bring a dangerous malaria infection under control. However, rapid improvement does not always mean that treatment is complete. Patients may need a follow-on oral antimalarial regimen according to the malaria species, severity, local treatment protocol, and clinical response. Never stop treatment simply because fever or chills improve.

How Artesunate Works

Artesunate in Combither AT 60 mg Injection is converted in the body to an active metabolite that damages malaria parasites. The drug interferes with essential parasite processes and produces toxic effects inside the parasite, helping destroy infected organisms. This rapid activity makes injectable artesunate an important medicine in hospital management of serious malaria.

Combither AT 60mg Injection should therefore be viewed as part of a medically directed treatment plan, not as a standalone product for self-treatment. The clinician may use laboratory testing, parasite identification, blood counts, kidney and liver assessments, and the patient’s symptoms to guide treatment.

Related Product

Administration and Dosage

A qualified healthcare professional should prepare and administer Combither AT 60mg Injection according to the prescribed regimen. The clinician should document each dose of Combither AT 60mg Injection. The exact dose and schedule depend on factors such as body weight, age, severity of infection, route of administration, and the treatment protocol being followed. Do not calculate or change the dose yourself.

The injection may be administered by a clinical route selected by the healthcare team. The team should use Combither AT 60mg Injection only as prescribed. Patients should remain under observation when severe malaria is suspected because the infection itself can cause rapid complications. Follow every instruction from the treating clinician and complete any subsequent oral antimalarial course exactly as prescribed.

Side Effects and Safety

Some patients receiving Combither AT 60 mg Injection may experience headache, dizziness, weakness, nausea, vomiting, abdominal discomfort, diarrhea, or discomfort at the injection site. Many adverse effects are temporary, but patients should tell their healthcare professional about persistent, severe, or unusual symptoms.

Artesunate treatment also requires appropriate follow-up. Delayed hemolysis can occur after artesunate therapy, so clinicians may monitor blood counts and related laboratory findings after treatment, particularly in patients treated for severe malaria. Seek urgent medical attention for severe weakness, unusual shortness of breath, fainting, dark urine, yellowing of the skin or eyes, or other concerning symptoms.

Tell the clinician about allergies, pregnancy, breastfeeding, kidney or liver problems, other medical conditions, and every medicine or supplement being used. This information helps the healthcare team assess risks and choose appropriate therapy. Do not use Combither AT 60mg Injection if you have a known serious allergy to artesunate or any component of the prescribed product.

Storage and Handling

Combither AT 60 mg Injection should remain in its original packaging and be stored according to the manufacturer’s labeled conditions. One current reference advises storage below 30°C. Healthcare professionals should check the vial, expiry date, packaging, and preparation instructions before administration. Patients should never reconstitute or inject the medicine themselves.

Why Choose a Licensed Pharmacy?

If your clinician has prescribed Combither AT 60mg Injection, obtain it through a legitimate, licensed pharmacy or healthcare facility. A regulated supply chain helps ensure that the product is sourced, stored, handled, and dispensed appropriately. Before ordering, verify the exact strength, dosage form, manufacturer, packaging, expiry date, and prescription requirements. Avoid websites that promise prescription medicines without appropriate clinical review or offer products with unclear sourcing.

For safe purchasing, use a licensed pharmacy and follow local prescription rules. Combither AT 60mg Injection should never be marketed as a guaranteed cure or used simply because someone has fever. Malaria diagnosis and treatment require professional evaluation, and severe symptoms require urgent care.

Frequently Asked Questions

What is Combither AT 60mg Injection used for?

Combither AT 60 mg Injection is an artesunate-containing antimalarial injection used for malaria treatment, particularly when injectable therapy is clinically appropriate.

Can I inject Combither AT 60mg Injection myself?

No. A trained healthcare professional should prepare and administer it. Self-injection can cause incorrect dosing, preparation errors, contamination, or serious harm.

Is Combither AT 60mg Injection a cure for malaria?

It is an effective antimalarial medicine, but treatment depends on the type and severity of malaria. Severe infections often require additional therapy and follow-up. A clinician should determine the complete treatment plan.

How quickly does it work?

Artesunate has rapid antimalarial activity, but the clinical response varies. Severe malaria requires hospital-level monitoring even when symptoms begin to improve.

Can children receive it?

Children can receive injectable artesunate when clinically indicated, but dosing is weight-based and must be determined by a qualified clinician.